|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 978.90 INR | -1.62% |
|
+5.47% | +30.26% |
| 05-28 | Supriya Lifescience Limited, Q4 2026 Earnings Call, May 28, 2026 | |
| 05-27 | Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 78.78B 827M 723M 665M 620M 1.18B 1.19B 7.98B 3.1B 38.73B 3.11B 3.04B 133B | P/E 2026 |
21.6x | P/E 2027 * | 32.7x |
|---|---|---|---|---|---|
| Enterprise Value | 78.78B 827M 723M 665M 620M 1.18B 1.19B 7.98B 3.1B 38.73B 3.11B 3.04B 133B | EV / Sales 2026 |
5.46x | EV / Sales 2027 * | 7.93x |
| Free-Float |
28.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supriya Lifescience Limited
| 1 day | -1.62% | ||
| 1 week | +5.47% | ||
| Current month | -3.85% | ||
| 1 month | +2.81% | ||
| 3 months | +59.90% | ||
| 6 months | +30.42% | ||
| Current year | +30.26% |
| 1 week | 913.3 |  | 1,043.2 |
| 1 month | 906.15 | | 1,043.2 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 233.3 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 34 | 2024-07-31 | |
| Chief Executive Officer | 36 | 2024-07-31 | |
| Director of Finance/CFO | - | 2023-01-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2008-03-25 | |
| Director/Board Member | 41 | 2019-05-31 | |
| Director/Board Member | 36 | 2019-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.62% | +5.47% | +33.13% | +302.01% | 827M | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.72% | +4.20% | +31.21% | +82.24% | 369.32B | |
| Weighted average by Cap. | +2.24% | +5.53% | +41.78% | +83.05% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.4B 88.22M 77.12M 70.88M 66.07M 125M 127M 851M 331M 4.13B 331M 324M 14.23B | 9.94B 104M 91.22M 83.83M 78.14M 148M 150M 1.01B 391M 4.88B 392M 383M 16.83B |
| Net income | 2B 21.02M 18.37M 16.88M 15.74M 29.85M 30.3M 203M 78.8M 984M 78.88M 77.19M 3.39B | 2.41B 25.3M 22.12M 20.33M 18.95M 35.94M 36.48M 244M 94.86M 1.18B 94.97M 92.93M 4.08B |
| Net Debt | - | - |
Employees
515
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹978.90 | -1.62% | 193,627 |
| 26-07-02 | ₹995.00 | -1.42% | 342,595 |
| 26-07-01 | ₹1,009.30 | -0.86% | 301,102 |
| 26-06-30 | ₹1,018.05 | +4.87% | 1,116,775 |
| 26-06-29 | ₹970.75 | +4.59% | 373,588 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
